Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Palm-Sized Device Facilitates Grommet Tube Placement

By HospiMedica International staff writers
Posted on 05 Jun 2017
A novel sensor-guided device that automates Grommet tube placement surgery significantly improves surgical treatment of Otitis Media with Effusion (OME).

Developed by researchers at the National University of Singapore (NUS, Singapore), the pistol-shaped CLiKX device uses a sensor-controlled automation process to deliver the grommet tube into a patient’s ear quickly and safely, minimizing overall contact time with the patient’s eardrum and preventing over-deformation and excessive pressure, thereby reducing discomfort and trauma. More...
To carry out the procedure, surgeons can potentially deploy a simple eye-loupe that does not require bulky surgical microscopes, using only moderate sedation or local anesthetic.

“The first line therapy for OME is usually the prescription of antibiotics and treatment of blocked ear tubes. But sometimes, the antibiotics may not be effective against OME,” said Lynne Lim, MD, of the NUS department of otolaryngology. “For patients with three or more episodes of OME within a year, especially if there is hearing loss and speech difficulties, some with craniofacial predispositions, or those who are concerned about building resistance to long term use of antibiotics, grommet tube placement surgery is currently the gold standard of care.”

“With this pistol-like applicator, the grommet tube can be easily inserted into a patient’s ear within a single click. In less than a second, the procedure is done,” added Professor Tan Kok Kiong, PhD, of the NUS department of electrical and computer engineering. “This simple procedure has the potential to be administered in a doctor’s consultation room under local anesthesia, or out of the operating theatre under intravenous conscious sedation without general anesthesia. Preoperative preparation and postoperative recovery time for patients are significantly reduced.”

OME is characterized by a non-purulent effusion of the middle ear that may be either mucoid or serous. Symptoms usually involve hearing loss or aural fullness but typically do not involve pain or fever. In general, inpatient care for OME is not required unless complications that threaten the stability of the patient's condition are suspected. A number of medical interventions besides grommets have been suggested for the treatment of OME, including pressure equalization tubes (PETs) and adenoidectomy.

Related Links
National University of Singapore


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.